Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Current Deferred Revenue (2021 - 2025)

Volitionrx (VNRX) has disclosed Current Deferred Revenue for 5 consecutive years, with $354000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Deferred Revenue rose 267.89% year-over-year to $354000.0, compared with a TTM value of $354000.0 through Sep 2025, up 267.89%, and an annual FY2024 reading of $230000.0, up 115.76% over the prior year.
  • Current Deferred Revenue was $354000.0 for Q3 2025 at Volitionrx, up from $122441.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $22.9 million in Q2 2024 and bottomed at $12512.0 in Q4 2021.
  • Average Current Deferred Revenue over 5 years is $4.7 million, with a median of $292000.0 recorded in 2024.
  • The sharpest move saw Current Deferred Revenue surged 79823.27% in 2022, then tumbled 99.47% in 2025.
  • Year by year, Current Deferred Revenue stood at $12512.0 in 2021, then soared by 79823.27% to $10.0 million in 2022, then tumbled by 98.93% to $106600.0 in 2023, then skyrocketed by 115.76% to $230000.0 in 2024, then soared by 53.91% to $354000.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for VNRX at $354000.0 in Q3 2025, $122441.0 in Q2 2025, and $230000.0 in Q1 2025.